Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
Active & Responsive
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
for
Acute Myeloid Leukemia, Pediatric AML
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 0 - 30
Code: NCT07059975
Early Phase 1, Recruiting
Active & Responsive
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
for
Myopia
Location: Houston TX, Memphis TN, Birmingham AL, Bloomington IN,
Sponsor: Ohio State University
Sex: All
Age: 6 - 11
Code: NCT07567040
Phase 3, Recruiting
Active & Responsive
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for
Major Depressive Disorder (MDD), Depression in Adults,
Location: Houston TX, San Antonio TX, DeSoto TX, New Orleans LA,
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06793397
Phase 3, Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: Houston TX, Greeley CO, Chicago IL, Minneota MN,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Houston TX, Bellaire TX, Pasadena TX, Sugar Land TX,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Houston TX, Temple TX, Hattiesburg MS, Little Rock AR,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Houston TX, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07281079
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
for
Amyotrophic Lateral Sclerosis
Location: Houston TX, Columbia MO, Columbus OH, Phoenix AZ,
Sponsor: Insmed Gene Therapy LLC
Sex: All
Age: 18 - 70+
Code: NCT07290062
Phase 1, Recruiting
Active & Responsive
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
for
Advanced Breast Cancer, Early Breast Cancer
Location: Houston TX, New Orleans LA, Hot Springs AR, Athens GA,
Sponsor: TerSera Therapeutics LLC
Sex: Female
Age: 18 - 55
Code: NCT07310420
Phase 1, Recruiting
Active & Responsive
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Houston TX, Santa Fe NM, Detroit MI, Irvine CA,
Sponsor: Xerient Pharma
Sex: All
Age: 18+
Code: NCT07157033
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease